- Liquid biopsy company Angle launched a share issue to raise £18.0m to develop its products, establish a service laboratroy and strengthen its balance sheet.

News shares in the company were being offered at 61.5p each.

'We are grateful for the strong support of existing and new shareholders as we build our business to address the global liquid biopsy market,' chief executive Andrew Newland said.

'As well as strengthening the company's balance sheet in preparation for negotiating corporate partnerships, the proceeds from the placing will allow us to establish a clinically approved service laboratory to drive business from pharmaceutical drug trials and accelerate use of the Parsortix system for treating patients.'

At 1:22pm: [LON:AGL] Angle PLC share price was +4p at 65.5p

Story provided by